HOYA (7741) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
15 Jul, 2026Executive summary
Consolidated revenue and operating profit reached historical highs in Q4 FY25, driven by strong demand in the Information Technology business.
Full-year performance was supported by robust IT business (mask blanks, HDD substrates) and growth in the Imaging and Life Care segments.
Financial highlights
Q4 FY25 revenue: ¥248.1bn, up 15% year-over-year (CC +9%).
Q4 operating profit: ¥74.7bn, up 14% year-over-year (CC +10%).
Q4 pretax profit: ¥76.6bn, up 15% year-over-year (CC +12%).
Full-year FY25 revenue: ¥947.7bn, up 9% (CC +8%). Operating profit: ¥285.2bn, up 12% (CC +11%). Pretax profit: ¥327.7bn, up 26% (CC +26%).
Outlook and guidance
FY26 targets stable growth in eyeglass lenses via high-value-added products and expansion in progressive lenses.
Plans to expand sales of ATIOLS and stabilize supply in IOLS segment.
Focus on expanding high-value-added masks in FPD and non-digital camera segments in Imaging.
Continued investment in production capacity for EUV blanks and HDD substrates.
Latest events from HOYA
- Record revenue and profit growth, improved margins, and a ¥200bn share buyback announced.7741
Q1 2027 - Record Q3 profit and revenue growth fueled by strong segments and one-time gains.7741
Q3 2026 - Record revenue, profit, and cash flow, with robust shareholder returns and ESG progress.7741
Q2 2026 - Record revenue and profit growth, driven by Life Care and IT, with a strong outlook ahead.7741
Q1 2026 - Information Technology drove double-digit profit growth despite Life Care's IT challenges.7741
Q1 2025 - Information Technology drove double-digit revenue growth, offsetting Life Care's medical challenges.7741
Q2 2025 - Record FY24 growth, new 40% dividend policy, and strong IT/Life Care performance.7741
Q4 2025 - Q3 profit before tax surged 31.3% on IT strength; full-year outlook remains strong.7741
Q3 2025